Recombinant, chimaeric live, attenuated vaccine (ChimeriVax&unknown;) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective i

By Monath T.P.   Soike K.   Levenbook I.   Zhang Z.-X.   Arroyo J.   Delagrave S.   Myers G.   Barrett A.D.T.   Shope R.E.   Ratterree M.   Chambers T.J.   Guirakhoo F.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1869-1882

Elsevier

Access to resources Recommend Favorite

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

By Pugachev K.V.   Ocran S.W.   Guirakhoo F.   Furby D.   Monath T.P.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 996-999

Elsevier

Access to resources Recommend Favorite

Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man

By Niedrig M.   Stolte N.   Fuchs D.   Hunsmann G.   Stahl-Hennig C.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1206-1210

Elsevier

Access to resources Recommend Favorite

A rapid test for measuring the infectivity of Yellow Fever vaccine

By Sood D.K.   Aggarwal R.K.   Kumar S.   Sokhey J.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 427-428

Elsevier

Access to resources Recommend Favorite

Yellow fever vaccine safety: a reality or a myth?

By Arya S.C.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3627-3628

Elsevier

Access to resources Recommend Favorite